Brought to you by 
Valocor spins off from QLT, closes seed round
29 Mar 2021
Executive Summary
Valocor Therapeutics Inc. (dermatology drug candidates) has spun out from QLT Inc. with undisclosed seed money from a group led by GrowthWorks Capital that included angel investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Valocor spins off from QLT, closes seed round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice